Dali Pharmaceuticalco.,Ltd (603963.SS)

4.2600 -0.2200 (-4.91%) As of 10:17AM CST. Market open.

Dali Pharmaceuticalco.,Ltd

No. 118, West Huancheng Road
Xiaguan Town
Dali 671000
China
86 87 2888 0055
https://www.daliyaoye.cn

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jun Xiang Yang	Chairman of the Board & GM	N/A	N/A	1962
Mr. Shao Yun Li	Deputy GM & CFO	N/A	N/A	1969
Mr. Jun Wei Yang	Assistant GM, Manager of Supply Department & Director	N/A	N/A	1965
Mr. Peirong Wu	Board Secretary	N/A	N/A	1986

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection. The company's products include xingnaojing, shenmai, and astragalus injections, as well as citicoline injections. It also has patents, including invention patents and utility models. The company was founded in 1996 and is headquartered in Dali, China.

Corporate governance

Dali Pharmaceuticalco.,Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.